| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702618 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
MRI-TRUS fusion focal cryotherapy is feasible in most patients and seems to accurately guide ablation demonstrated by posttreatment imaging. Additional studies are needed to determine efficacy using postcryotherapy biopsy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Massimo M.D., Ph.D., Taimur Tariq M.R.C.S., Paras Shah, Neil Mccartan, Mark M.D., Manit M.D., Hashim Uddin Ph.D.,